These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 16010860)

  • 21. Non-traditional study designs to demonstrate average bioequivalence for highly variable drug products.
    Patterson SD; Zariffa NM; Montague TH; Howland K
    Eur J Clin Pharmacol; 2001 Nov; 57(9):663-70. PubMed ID: 11791897
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetics and bioequivalence study of valacyclovir hydrochloride capsules after single dose administration in healthy Chinese male volunteers.
    Lin H; Tian Y; Tian JX; Zhang ZJ; Mao GG
    Arzneimittelforschung; 2010; 60(3):162-7. PubMed ID: 20422949
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bioequivalence evaluation of two brands of lisinopril tablets by in vitro comparative dissolution test and in vivo bioequivalence test.
    Shin MC; Kim JK; Kim CK
    Arzneimittelforschung; 2008; 58(1):11-7. PubMed ID: 18368945
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel multivariate approach for estimating the degree of similarity in bioavailability between two pharmaceutical products.
    Hsu HC; Lu HL; Chan KK
    J Pharm Sci; 1995 Jun; 84(6):768-72. PubMed ID: 7562420
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bioequivalence evaluation of sparse sampling pharmacokinetics data using bootstrap resampling method.
    Shen M; Machado SG
    J Biopharm Stat; 2017; 27(2):257-264. PubMed ID: 27906608
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The existence of sequence effect in cross-over bioequivalence trials.
    Zintzaras E
    Eur J Drug Metab Pharmacokinet; 2000; 25(3-4):241-4. PubMed ID: 11420897
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of average and population bioequivalence approach.
    Nakai K; Fujita M; Tomita M
    Int J Clin Pharmacol Ther; 2002 Sep; 40(9):431-8. PubMed ID: 12358161
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Particle Size Distribution Equivalency as Novel Predictors for Bioequivalence.
    Ngeacharernkul P; Stamatis SD; Kirsch LE
    AAPS PharmSciTech; 2018 Oct; 19(7):2787-2800. PubMed ID: 30117041
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bioequivalence of two lamivudine tablet formulations.
    Santos-Magalhães NS; Pontes A; Cavalcante RM; Costa RM; Rangel FA; Guimarães MI; de Carvalho JN; de Souza SD; de Oliveira HM; Esteves IL; Ramalho MS; Vieira SL; Alves AJ
    Arzneimittelforschung; 2001; 51(4):310-4. PubMed ID: 11367872
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantitative assessment of the switchability of generic products.
    Karalis V; Bialer M; Macheras P
    Eur J Pharm Sci; 2013 Nov; 50(3-4):476-83. PubMed ID: 23981332
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [New guidelines for the assessment of bioavailability and bioequivalence].
    Blume H; Schug B; Tautz J; Erb K
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2005 May; 48(5):548-55. PubMed ID: 15887065
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics and bioequivalence study of three oral formulations of valsartan 160 mg: a single-dose, randomized, open-label, three-period crossover comparison in healthy Indian male volunteers.
    Iqbal M; Khuroo A; Batolar LS; Tandon M; Monif T; Sharma PL
    Clin Ther; 2010 Mar; 32(3):588-96. PubMed ID: 20399995
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of bioequivalence of highly variable drugs using clinical trial simulations. II: Comparison of single and multiple-dose trials using AUC and Cmax.
    el-Tahtawy AA; Tozer TN; Harrison F; Lesko L; Williams R
    Pharm Res; 1998 Jan; 15(1):98-104. PubMed ID: 9487554
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetic comparisons between two formulations containing 100 mg of miglitol in healthy male Korean volunteers: a randomized, open-label, single-dose, two-period, two-sequence crossover bioequivalence study.
    Choi HG; Jeon JY; Im YJ; Kim Y; Jang H; Kang S; Kim KH; Chae SW; Lee SY; Kim MG
    Int J Clin Pharmacol Ther; 2014 Jan; 52(1):55-63. PubMed ID: 24290415
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Biological availability of gastric juice-resistant coated diclofenac preparations. 1. Bioavailability study following a single administration of a multiple-unit formulation in comparison with a single-unit formulation].
    Scheidel B; Blume H; Walter K; von Nieciecki A; Babej-Dölle RM
    Arzneimittelforschung; 1993 Nov; 43(11):1211-5. PubMed ID: 8292067
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative bioavailability of two tablet formulations of acyclovir in healthy volunteers.
    Al-Yamani MJ; Al-Khamis KI; El-Sayed YM; Bawazir SA; Al-Rashood KA; Gouda MW
    Int J Clin Pharmacol Ther; 1998 Apr; 36(4):222-6. PubMed ID: 9587049
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bioequivalence study of two losartan formulations administered orally in healthy male volunteers.
    Bienert A; Brzezińiski R; Szałek E; Dubai V; Grześkowiak E; Dyderski S; Drobnik L; Wolc A; Olejniczak-Rabinek M
    Arzneimittelforschung; 2006; 56(11):723-8. PubMed ID: 17220048
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A replicate study design for testing bioequivalence: a case study on two desmopressin nasal spray preparations.
    Joukhadar C; Schenk B; Kaehler ST; Kollenz CJ; Bauer P; Müller M; Eichler HG
    Eur J Clin Pharmacol; 2003 Nov; 59(8-9):631-6. PubMed ID: 14564429
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comparison of moment-based and probability-based criteria for assessment of follow-on biologics.
    Chow SC; Hsieh TC; Chi E; Yang J
    J Biopharm Stat; 2010 Jan; 20(1):31-45. PubMed ID: 20077247
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics and comparative bioavailability of two fenofibrate capsule formulations in healthy volunteers.
    Vlase L; Popa A; Muntean D; Leucuta SE
    Arzneimittelforschung; 2010; 60(9):560-3. PubMed ID: 21117499
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.